Cargando…

Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study

BACKGROUND: Experimental evidence in tumor-bearing mouse models shows that exposure to cool, that is, sub-thermoneutral environmental temperature is associated with a higher tumor growth rate with an immunosuppressive tumor immune microenvironment than seen at thermoneutral temperatures. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ashish, Gupta, Kush, Roy, Arya Mariam, Attwood, Kristopher, Gandhi, Asha, Edge, Stephen, Takabe, Kazuaki, Repasky, Elizabeth, Yao, Song, Gandhi, Shipra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081359/ https://www.ncbi.nlm.nih.gov/pubmed/37034618 http://dx.doi.org/10.21203/rs.3.rs-2718368/v1

Ejemplares similares

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
por: Abdou, Yara, et al.
Publicado: (2022)

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?
por: Gupta, Ravi Kumar, et al.
Publicado: (2022)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
por: Gandhi, Shipra, et al.
Publicado: (2021)

Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer
por: Roy, Arya Mariam, et al.
Publicado: (2023)

Effect of Neighborhood Deprivation Index on Breast Cancer Survival in the United States
por: Roy, Arya Mariam, et al.
Publicado: (2023)

Effect of neighborhood deprivation index on breast cancer survival in the United States
por: Roy, Arya Mariam, et al.
Publicado: (2023)

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
por: Wu, Rongrong, et al.
Publicado: (2022)

Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience
por: Alaklabi, Sabah, et al.
Publicado: (2022)

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer
por: Gandhi, Shipra, et al.
Publicado: (2020)

Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020)

Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward
por: Gupta, Kush, et al.
Publicado: (2021)

Limb‐sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high‐grade, extremity soft‐tissue sarcoma from the NCDB and SEER
por: Ramey, Stephen J., et al.
Publicado: (2018)

Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies
por: Gosain, Rohit, et al.
Publicado: (2020)

Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis
por: Roy, Arya Mariam, et al.
Publicado: (2023)

Primary and secondary breast angiosarcoma: single center report and a meta-analysis
por: Abdou, Yara, et al.
Publicado: (2019)

Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer
por: Murthy, Vijayashree, et al.
Publicado: (2021)

Complete Remission of Bone Metastases in Renal Cell Carcinoma with Nivolumab
por: Vuyyala, Sowjanya, et al.
Publicado: (2019)

Behind the clock: elucidating factors contributing to longer clinic appointment duration and patient wait time
por: Kagedan, Daniel Jonathan, et al.
Publicado: (2021)

The Use of Radiation Therapy in Well-Differentiated Soft Tissue Sarcoma of the Extremities: An NCDB Review
por: Lazarides, Alexander L., et al.
Publicado: (2015)

Clinicopathological features, treatment patterns, and prognosis of squamous cell carcinoma of the breast: an NCDB analysis
por: Zhu, Liling, et al.
Publicado: (2019)

Rates of margin positive resection with breast conservation for invasive breast cancer using the NCDB
por: WJ, Hotsinpiller, et al.
Publicado: (2021)

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis
por: Chen, Kai, et al.
Publicado: (2015)

Exploring trends in advanced bladder cancer using the NCDB: turning data into information and information into insight
por: Thiruthaneeswaran, Niluja, et al.
Publicado: (2018)

Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
por: Gandhi, Shipra
Publicado: (2023)

Development of a novel BRCAness score that predicts response to PARP inhibitors
por: Oshi, Masanori, et al.
Publicado: (2022)

The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis
por: Huang, Binhao, et al.
Publicado: (2021)

Colorectal cancer in the 45-to-50 age group in the United States: a National Cancer Database (NCDB) analysis
por: Reif de Paula, Thais, et al.
Publicado: (2021)

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
por: Liu, Jieqiong, et al.
Publicado: (2015)

A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

A Novel Three-Gene Score as a Predictive Biomarker for Pathologically Complete Response after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2021)

Abstract QS2: Influence of Race, Income, Insurance and Education in Rate of Breast Reconstruction: an NCDB 2004–15 Analysis
por: Restrepo, David J., et al.
Publicado: (2019)

Prognostic and Predictive Value of Circulating and Disseminated Tumor Cells in Breast Cancer: A National Cancer Database (NCDB) Analysis
por: Bilani, Nadeem, et al.
Publicado: (2020)

Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016)
por: Goldbach, Macy M., et al.
Publicado: (2021)

Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016
por: Sussman, Tamara A, et al.
Publicado: (2022)

Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review
por: Rodriguez, Robin R., et al.
Publicado: (2021)

Chondrosarcoma patient characteristics, management, and outcomes based on over 5,000 cases from the National Cancer Database (NCDB)
por: Ottesen, Taylor D., et al.
Publicado: (2022)

Long-Term 5-Year Response to Pembrolizumab, Bevacizumab, and Capecitabine Regimen in a Metastatic Colon Cancer Patient with MSI-High and KRAS Mutation: Case Report
por: Julka, Pramod Kumar, et al.
Publicado: (2023)

21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
por: Parsons, Benjamin M., et al.
Publicado: (2016)

Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
por: Stafford, Arielle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0jh8nkrsh0rp093ao61ckfksa7